Details of the Drug
General Information of Drug (ID: DM71EMN)
| Drug Name |
3-(ethoxycarbonyl)phenylboronic acid
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
3-Ethoxycarbonylphenylboronic acid; 4334-87-6; 3-(Ethoxycarbonyl)phenylboronic acid; (3-ethoxycarbonylphenyl)boronic Acid; 3-carbethoxyphenylboronic acid; (3-(ethoxycarbonyl)phenyl)boronic acid; m-ethoxycarbonylphenylboronic acid; 3-Ethoxycarbonylbenzeneboronic acid; Ethyl 3-(Dihydroxyboranyl)Benzoate; MFCD02179444; [3-(ethoxycarbonyl)phenyl]boronic acid; 3-(ethoxycarbonyl)benzeneboronic acid; 3-(ethoxycarbonyl)phenyl boronic acid; Akos Brn-0097; BENZOIC ACID, 3-BORONO-, 1-ETHYL ESTER; PubChem6092; Phenylboronic Acid, 2
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 |
Molecular Weight | 193.99 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient | Not Available | ||||||||||||||||||||||
| Rotatable Bond Count | 4 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count | 4 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


